Cargando…
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas
PTEN is a novel tumour-suppressor gene located on chromosomal band 10q23.3. This region displays frequent loss of heterozygosity (LOH) in a variety of human neoplasms including breast carcinomas. The detection of PTEN mutations in Cowden disease and in breast carcinoma cell lines suggests that PTEN...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362671/ https://www.ncbi.nlm.nih.gov/pubmed/10070865 http://dx.doi.org/10.1038/sj.bjc.6690121 |
_version_ | 1782153511431045120 |
---|---|
author | Freihoff, D Kempe, A Beste, B Wappenschmidt, B Kreyer, E Hayashi, Y Meindl, A Krebs, D Wiestler, O D Deimling, A von Schmutzler, R K |
author_facet | Freihoff, D Kempe, A Beste, B Wappenschmidt, B Kreyer, E Hayashi, Y Meindl, A Krebs, D Wiestler, O D Deimling, A von Schmutzler, R K |
author_sort | Freihoff, D |
collection | PubMed |
description | PTEN is a novel tumour-suppressor gene located on chromosomal band 10q23.3. This region displays frequent loss of heterozygosity (LOH) in a variety of human neoplasms including breast carcinomas. The detection of PTEN mutations in Cowden disease and in breast carcinoma cell lines suggests that PTEN may be involved in mammary carcinogenesis. We here report a mutational analysis of tumour specimens from 103 primary breast carcinomas and constitutive DNA from 25 breast cancer families. The entire coding region of PTEN was screened by single-strand conformation polymorphism (SSCP) analysis and direct sequencing using intron-based primers. No germline mutations could be identified in the breast cancer families and only one sporadic carcinoma carried a PTEN mutation at one allele. In addition, all sporadic tumours were analysed for homozygous deletions by differential polymerase chain reaction (PCR) and for allelic loss using the microsatellite markers D10S215, D10S564 and D10S573. No homozygous deletions were detected and only 10 out of 94 informative tumours showed allelic loss in the PTEN region. These results suggest that PTEN does not play a major role in breast cancer formation. 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23626712009-09-10 Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas Freihoff, D Kempe, A Beste, B Wappenschmidt, B Kreyer, E Hayashi, Y Meindl, A Krebs, D Wiestler, O D Deimling, A von Schmutzler, R K Br J Cancer Regular Article PTEN is a novel tumour-suppressor gene located on chromosomal band 10q23.3. This region displays frequent loss of heterozygosity (LOH) in a variety of human neoplasms including breast carcinomas. The detection of PTEN mutations in Cowden disease and in breast carcinoma cell lines suggests that PTEN may be involved in mammary carcinogenesis. We here report a mutational analysis of tumour specimens from 103 primary breast carcinomas and constitutive DNA from 25 breast cancer families. The entire coding region of PTEN was screened by single-strand conformation polymorphism (SSCP) analysis and direct sequencing using intron-based primers. No germline mutations could be identified in the breast cancer families and only one sporadic carcinoma carried a PTEN mutation at one allele. In addition, all sporadic tumours were analysed for homozygous deletions by differential polymerase chain reaction (PCR) and for allelic loss using the microsatellite markers D10S215, D10S564 and D10S573. No homozygous deletions were detected and only 10 out of 94 informative tumours showed allelic loss in the PTEN region. These results suggest that PTEN does not play a major role in breast cancer formation. 1999 Cancer Research Campaign Nature Publishing Group 1999-02 /pmc/articles/PMC2362671/ /pubmed/10070865 http://dx.doi.org/10.1038/sj.bjc.6690121 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Freihoff, D Kempe, A Beste, B Wappenschmidt, B Kreyer, E Hayashi, Y Meindl, A Krebs, D Wiestler, O D Deimling, A von Schmutzler, R K Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title_full | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title_fullStr | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title_full_unstemmed | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title_short | Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas |
title_sort | exclusion of a major role for the pten tumour-suppressor gene in breast carcinomas |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362671/ https://www.ncbi.nlm.nih.gov/pubmed/10070865 http://dx.doi.org/10.1038/sj.bjc.6690121 |
work_keys_str_mv | AT freihoffd exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT kempea exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT besteb exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT wappenschmidtb exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT kreyere exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT hayashiy exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT meindla exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT krebsd exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT wiestlerod exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT deimlingavon exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas AT schmutzlerrk exclusionofamajorrolefortheptentumoursuppressorgeneinbreastcarcinomas |